Patients in the UK could face delays getting new drugs if the UK withdraws from the EU’s medicines regulator, due to Brexit
Former UK medicines regulator Sir Alasdair Breckenridge said on BBC Radio 4’s Today program yesterday that. “The UK market compared to the European market, of course, is small and they may decide not to come to the United Kingdom.
“So, therefore, there will be a delay in getting new drugs – important new drugs, anti-cancer drugs, anti-infective drugs – for patients in the UK.”
Let’s hope that this is just scaremongering.
For the full report of the interview please see http://www.bbc.co.uk/news/health-38922366